Clinical review for general practice

ISSN (Print) 2713-2552
ISSN (Online) 2782-5671
  • Home
  • about
  • archives
  • contacts
left
FULLSCREEN > Archive > 2022 > Vol 3, №1 (2022) > A clinical case of endoscopic diagnosis of signet ring cell cancer of the antrum of the stomach

A clinical case of endoscopic diagnosis of signet ring cell cancer of the antrum of the stomach

Ivan V. Smirnov

For citation:


  • Abstract
  • About the Author
  • References

Abstract

Signet ring cell cancer (SRC) is a rare form of high-grade adenocarcinoma that produces mucin. This is an epithelial malignant tumor characterized by the histological appearance of cells resembling rings. Primary SRC tumors are most often found in the glandular cells of the stomach (SRC occurs in the stomach in 56% of patients) and less often in the mammary gland, gallbladder, bladder and pancreas. SRC usually does not form in the lungs, although several cases have been reported. Among cases of colorectal cancer, the prevalence of SRC is less than one percent. Although the incidence and mortality from stomach cancer have decreased in many countries over the past 50 years, there has been an increase in the number of cases of stomach cancer of the type of SRC. As a rule, SRC grows in the submucosal layer, which makes diagnostics using standard imaging methods, such as computed tomography and positron emission tomography, less effective. In this clinical case, the possibilities of endoscopic diagnosis of SRC in a patient who has not been able to establish a correct diagnosis for a long time have been demonstrated.
Key words: tumor, adenocarcinoma, signet cell carcinoma, stomach.

About the Author

Ivan V. Smirnov 1

1 Vologda Regional Clinical Hospital, Vologda, Russia

References

1. Zimaity HM, Itani K, Graham DY. Early diagnosis of signet ring cell carcinoma of the stomach: role of the Genta stain. J Clin Pathol 1997; 50 (10): 867–8. DOI: 10.1136/jcp.50.10.867
2. Benesch MG, Mathieson A. Epidemiology of Signet Ring Cell Adenocarcinomas. Cancers 2020; 12 (6): E1544. DOI: 10.3390/cancers12061544
3. Belli S, Aytac HO, Karagulle E et al. Outcomes of surgical treatment of primary signet ring cell carcinoma of the colon and rectum: 22 cases reviewed with literature. Int Surg 2014; 99 (6): 691–8. DOI: 10.9738/INTSURG-D-14-00067.1
4. Kunisaki C, Shimada H, Takahashi M et al. Therapeutic strategy for gastric cancer with signet ring cell carcinoma. 5th International gastric cancer congress, Rome, May 4–7, 2003; p. 74.
5. Maehara Y, Sakaguchi Y, Moriguchi S et al. Signet ring cell carcinoma of the stomach. Cancer 1992; 69 (7): 1645–50. DOI: 10.1002/1097-0142(19920401)69:7<1645::aid-cncr2820690702>3.0.co;2-x
6. Watanabe H, Jass JR, Sobin LH et al. Histological Typing of Oesophageal and Gastric Tumours (International histological classification of tumours). 2nd ed. New York, 1990.
7. Неред С.Н., Клименков А.А., Перевощиков А.Г. Клинико-морфологические особенности перстневидно-клеточного рака желудка. М.: ГУ РОНЦ им. Н.Н. Блохина РАМН, 2004.
[Nered S.N., Klimenkov A.A., Perevoshchikov A.G. Kliniko-morfologicheskie osobennosti perstnevidno-kletochnogo raka zheludka. Moscow: GU RONTs im. N.N. Blokhina RAMN, 2004 (in Russian).]
8. Hyung WJ, No SH, Shin DW et al. The biologic behavior of gastric signet ring cell carcinoma. 3th International gastric cancer congress, Seoul, Apr. 27–30, 1999; p. 91.
9. Kim JP, Kim SC, Yang HK. Prognostic significance of signet ring cell carcinoma of the stomach.Surg. Oncol 1994; 3 (4): 221–7. DOI: 10.1016/0960-7404(94)90037-x
10. Office of Rare Diseases Research: Diffuse Gastric Cancer. National Institute of Health. P. 84–5. Retrieved 2012-11-21.
11. Muta H, Noguchi M, Kanai Y et al. E-cadherin gene mutations in signet ring cell carcinoma of the stomach. Jpn J Cancer Res 1996; 87 (8): 843–8. DOI: 10.1111/j.1349-7006.1996.tb02109.x
12. Nakatsuru S, Yanagisawa A, Ichii S et al. Somatic mutation of the APC gene in gastric cancer: frequent mutations in very well differentiated adenocarcinoma and signet-ring cell carcinoma. Hum Mol Genet 1992; 1 (8): 559–63. DOI: 10.1093/hmg/1.8.559
13. Pernot S, Voron T, Perkins G et al. Signet-ring cell carcinoma of the stomach: Impact on prognosis and specific therapeutic challenge. World J Gastroenterol 2015; 21 (40): 11428–38. DOI: 10.3748/wjg. v21.i40.11428
14. Fukui Y. Mechanisms behind signet ring cell carcinoma formation. Biochem Biophys Res Commun 2014; 450 (4): 1231–3.
15. Portnoy LM. Radiologic diagnosis of gastric cancer: a new outlook. Springer Science & Business Media, 2006.
16. Huh CW, Jung DH, Kim JH et al. Signet ring cell mixed histology may show more aggressive behavior than other histologies in early gastric cancer. J Surgical Oncol 2013; 107 (2): 124–9. DOI: 10.1002/jso.23261
17. Hartman DJ, Nikiforova MN, Chang DT et al. Signet ring cell colorectal carcinoma: a distinct subset of mucin-poor microsatellite-stable signet ring cell carcinoma associated with dismal prognosis. Am J Surg Pathol 2013; 37 (7): 969–77. DOI: 10.1097/PAS.0b013e3182851e2b
18. Henson DE, Dittus C, Younes M et al. Differential trends in the intestinal and diffuse types of gastric carcinoma in the United States, 1973-2000: increase in the signet ring cell type. Archives of Pathology & Laboratory Medicine. 2004; 128 (7): 765–70. DOI: 10.5858/2004-128-765-DTITIA

For citation:Smirnov I.V. A clinical case of endoscopic diagnosis of signet ring cell cancer of the antrum of the stomach. Clinical review for general practice. 2022; 1: 44–48. DOI: 10.47407/kr2022.3.1.00117


All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

  • About
  • Editorial board
  • Ethics
  • For authors
  • Author fees
  • Peer review
  • Contacts

oa
crossref
анри


  Indexing

doaj
elibrary

Address of the Editorial Office:

127055, Moscow, s/m 37

Correspondence address:

115054, Moscow, Zhukov passage, 19, fl. 2, room XI


Managing Editor:

+7 (495) 926-29-83

id@con-med.ru